Skip to content

(Cost)-Effectiveness of two different strategies to improve the QUality of ANtibiotic use in patients with urinary Tract Infections (UTIs) in the hospital.

(Cost)-Effectiveness of two different strategies to improve the QUality of ANtibiotic use in patients with urinary Tract Infections (UTIs) in the hospital. A cluster-randomized controlled trial in 19 Dutch hospitals.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23008
Enrollment
19
Registered
2009-03-27
Start date
2008-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urinary tract infections, antibiotic use, quality indicators, implementation strategies, guidelines (urineweginfecties, antibioticagebruik, kwaliteitsindicatoren, implementatie strategieen, richtlijnen)

Interventions

After a baseline measurement, hospitals will be randomized between two implementation strategies: a theory-based and effective, but labour-intensive strategy (the 'state-of-the-art' strategy) versus a

Sponsors

University of Amsterdam, AMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hospitals will be randomized. For baseline- and postintervention measurement data will be extracted from medical charts of patients. Inclusion criteria for these patients are: 1. In- and outpatients from the departments Urology or Internal Medicine; 2. > 16 years; 3. Diagnosed and treated for a complicated UTI in 2008 (2007).

Exclusion criteria

Exclusion criteria: 1. No (treated) UTI; 2. Uncomplicated UTI; 3. Nephro drain; 4. JJ catheter; 5. < 16 years; 6. Diagnosed and treated for a complicated UTI before 2007.

Design outcomes

Primary

MeasureTime frame
Quality of antibiotic use (measured by clinically validated indicators).

Secondary

MeasureTime frame
1. Cost-effectiveness; 2. Successful elements of the implementation strategy.

Contacts

Public ContactV. Spoorenberg
v.spoorenberg@amc.uva.nl+31 (0)20 5666807

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)